A Carpi

Phase III Trial of Observation Versus Six Courses of Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer in Complete Response After Six Courses of Paclitaxel/Platinum-Based Chemotherapy: Final Results of the After-6 Protocol 1

S. Pecorelli, G. Favalli, Angiolo Gadducci et al. · Journal of Clinical Oncology · 2009 · 113 citations

Medicine, Gynecology, Oncology +17

Chemotherapy of advanced non-small-cell lung cancer: A comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.)

Lucio Crinò, M. Clerici, F. Figoli et al. · Annals of Oncology · 1995 · 84 citations

Medicine, Oncology, Pharmacotherapy +10

Capecitabine and oxaliplatin in advanced colorectal cancer: A dose-finding study

Massimo Zeuli, Emilio di Costanzo, Andrea Sdrobolini et al. · Annals of Oncology · 2001 · 25 citations · Full text

Medicine, Oncology, Pharmacology +14

A comparison of continuation versus late intensification followed by discontinuation of chemotherapy in advanced breast cancer. A prospective randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.)

Giorgio Cocconi, Giancarlo Bisagni, M. Bacchi et al. · Annals of Oncology · 1990 · 25 citations · Full text

Medicine, Oncology, Breast Oncology +5

Final results of After-6 protocol 1: A phase III trial of observation versus 6 courses of paclitaxel (Pac) in advanced ovarian cancer patients in complete response (CR) after platinum-paclitaxel chemotherapy (CT)

PierFranco Conte, G. Favalli, Angiolo Gadducci et al. · Journal of Clinical Oncology · 2007 · 20 citations

Medicine, Gynecology, Oncology +13